Douglas AG · ISIN: DE000BEAU7Y1 · Directors Dealings
Insider Transaction Snapshot

Douglas AG

Directors Dealings: 23rd December 2024
Reporting obligation triggered by: Langer, Mark Alexander
Trading volume: 196.970,00 EUR
Type: Buy

The Insider Transaction was made by Langer, Mark Alexander . The transaction toke place on 20th December 2024. The order was executed at the trading place XETRA. The aggregated volume was 196.970,00 EUR, based on an average price of 19,50 EUR. The nature of the Investment was Buy.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
This might be interesting for you as well
New DD.i/o
22 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 20th June 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 20th June 2022,

The Insider Transaction was made by GT 1 Vermögensverwaltung GmbH . The transaction toke place on 17th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 75.962,80 EUR, based on an average price of 37,98 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
17 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 17th June 2022. The reporting obligation was triggered by a person related to Other executive.

Transaction reporting date: 17th June 2022,

The Insider Transaction was made by Rauch, Michael . The transaction toke place on 16th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 73.278,06 EUR, based on an average price of 36,64 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
17 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 17th June 2022. The reporting obligation was triggered by a person related to Other executive.

Transaction reporting date: 17th June 2022,

The Insider Transaction was made by Reichl, Hannes . The transaction toke place on 16th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 55.106,98 EUR, based on an average price of 36,74 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
15 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 15th June 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 15th June 2022,

The Insider Transaction was made by Rauch, Julius Fynn . The transaction toke place on 15th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 18.954,55 EUR, based on an average price of 37,91 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
15 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 14th June 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 14th June 2022,

The Insider Transaction was made by Rauch, Magnus Tim . The transaction toke place on 14th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 39.067,58 EUR, based on an average price of 39,07 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
More CompuGroup Medical SE & Co. KGaA related information
Type Total Last Made by Go to
Equity Story 95 9th December 2024 EQS Group AG EQS
Corporate Research 0 - - Corporate Research
Short Seller (DE) 2 20th December 2024 Qube Research & Technologies Limited SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html